[KROS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 20.01%
YoY- 6.18%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 100 0 20,000 -
PBT -37,505 -35,804 -29,718 -23,509 -27,266 -24,186 -4,942 287.61%
Tax 3,832 -3,065 2 -4,467 -3,462 1 1,998 54.55%
NP -37,505 -32,739 -29,720 -19,042 -23,804 -24,187 -6,940 208.90%
Tax Rate - - - - - - - -
Total Cost 37,505 32,739 29,720 19,042 23,904 24,187 26,940 24.75%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 -23,804.00 0.00 -34.70 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 -0.30 162.38%
EPS Diluted -1.27 -1.15 -1.09 -0.75 -0.99 -1.01 -0.30 162.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.